Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Natural products can help overcome cancer drug resistance.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Targeting EGFR may help reduce hair loss from chemotherapy.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

A specific hair diffraction pattern may indicate breast cancer if tested with the correct method.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

Cefazolin-loaded nanoparticles in nanofibers can help heal wounds and support regeneration.

Chemotherapy caused a woman's permanent hair loss and early menopause.